GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC
Data sourced from IRS 990 public filings
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC TO ACCELERATE THE DISCOVERY & DEVELOPMENT OF NEW DRUGS TO FACILITATE THE CONTROL OF TUBERCULOSIS THROUGHOUT THE WORLD AND THE ACCESSIBILITY OF THESE DRUGS TO THE GLOBAL COMMUNITY.
Annual Revenue
$63,732,557
Known Funders
3
Grants Received
13
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $63,732,557 | $61,508,783 | $204,316,428 |
| 2023 | $60,240,486 | $55,378,579 | $197,319,541 |
| 2022 | $56,212,963 | $55,785,890 | $176,686,879 |
| 2021 | $58,653,379 | $57,430,605 | $187,560,796 |
| 2020 | $61,267,452 | $61,720,389 | $191,155,661 |
| 2019 | $174,873,899 | $69,535,079 | $189,418,881 |
| 2018 | $63,283,490 | $60,315,645 | $75,171,538 |
| 2017 | $58,006,498 | $56,120,604 | $72,985,406 |
Top Funders
SEATTLE, WA
SEATTLE, WA
SEATTLE, WA
SEATTLE, WA
SEATTLE, WA
SEATTLE, WA
SEATTLE, WA
GREENSBORO, NC
SEATTLE, WA
GREENSBORO, NC
Key Personnel
From 2024 IRS 990 filing
SANDEEP JUNEJA
SR. VP, MARKET ACCESS
SALAH FORAIDA
SR. DIRECTOR, MEDICAL AFFAIRS
ROBERT LORETTE
SR. VP, BUSINESS DEVELOPMENT
RAJNEESH TANEJA
VP, PHARMACEUTICAL PRODUCT DEVELOPMENT
KATHLEEN SCHOSTACK
SR. VP, PROGRAM & ALLIANCE MANAGEMENT
PIETRO O TURILLI
SR. VP, EXTERNAL AFFAIRS
MARIA BEUMONT
VP, CHIEF MEDICAL OFFICER
DR NADER FOTOUHI
SR. VP, CHIEF SCIENTIFIC OFFICER
DR EUGENE SUN
SR. VP, RESEARCH & DEVELOPMENT
COLLEEN PERO
SECRETARY/CAO
Showing 10 of 23 key personnel.
Frequently Asked Questions
Other Nonprofits in New York
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.